Diuretic effects of cannabinoid agonists in mice

European Journal of Pharmacology

Volumn 721, Issue 1-3, 2013, Pages 64-69

  Chopda, Girish R ^a   Vemuri, V Kiran ^a   Sharma, Rishi ^a   Thakur, Ganesh A ^a   Makriyannis, Alexandros ^a   Paronis, Carol A ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

9 Tetrahydrocannabinol; Bladder dysfunction; Cannabinoid; Diuresis; Mice; THC

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDEMETHANE SULFATE; 9BETA [HYDROXYMETHYL] 3 (1 ADAMANTYL)HEXAHYDROCANNABINOL; AM 4054; AM 7418; BUTYL 2 [6A,7,10,10A TETRAHYDRO 1 HYDROXY 9 (HYDROXYMETHYL) 6,6 DIMETHYL 6H BENZO[C]CHROMEN 3 YL] 2 METHYLPROPANOATE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 1 RECEPTOR ANTAGONIST; DRONABINOL; FUROSEMIDE; MORPHINE; PENTOBARBITAL; POTASSIUM ION; SODIUM ION; UNCLASSIFIED DRUG; WIN 55 212;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIURESIS; ELECTROLYTE URINE LEVEL; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SODIUM URINE LEVEL; URINALYSIS; URINE VOLUME;

BLADDER DYSFUNCTION; CANNABINOID; DIURESIS; MICE; THC; Δ(9)-TETRAHYDROCANNABINOL;

ANIMALS; CANNABINOID RECEPTOR AGONISTS; DIURETICS; ELECTROLYTES; HOMEOSTASIS; MALE; MICE; RECEPTOR, CANNABINOID, CB1; TIME FACTORS; WATER;

EID: 84890125504     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.09.053     Document Type: Article

References (26)

1. F. Ames A clinical and metabolic study of acute intoxication with Cannabis sativa and its role in the model psychoses Journal of Mental Science 104 1958 972 999
2. H. Barry 3rd, R.K. Kubena, and J.L. Perhach Jr. Pituitary-adrenal activation and related responses to delta1-tetrahydrocannabinol Progress in Brain Research 39 1973 323 330
3. C.M. Brady, R. DasGupta, C. Dalton, O.J. Wiseman, K.J. Berkley, and C.J. Fowler An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis Multiple Sclerosis 10 2004 425 433 (Pubitemid 39117340)
4. G. Chopda, J. Bergman, K. Vemuri, A. Makriyannis, and C.A. Paronis Possible efficacy related differences among cannabinoid agonists The FASEB Journal 27 2013 2
5. N.L. Cluny, V.K. Vemuri, A.P. Chambers, C.L. Limebeer, H. Bedard, J.T. Wood, B. Lutz, A. Zimmer, L.A. Parker, A. Makriyannis, and K.A. Sharkey A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents British Journal of Pharmacology 161 2010 629 642
6. P. Consroe, R. Musty, J. Rein, W. Tillery, and R. Pertwee The perceived effects of smoked cannabis on patients with multiple sclerosis European Neurology 38 1997 44 48 (Pubitemid 27283078)
7. N. Dmitrieva, and K.J. Berkley Contrasting effects of WIN 55212-2 on motility of the rat bladder and uterus Journal of Neuroscience 22 2002 7147 7153 (Pubitemid 35379169)
8. S.J. Gatley, A.N. Gifford, N.D. Volkow, R. Lan, and A. Makriyannis 123I-labeled AM251: a radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors European Journal of Pharmacology 307 1996 331 338 (Pubitemid 26233375)
9. D.R. Kapusta, and J.C. Obih Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves Journal of Pharmacology and Experimental Therapeutics 267 1993 197 204 (Pubitemid 23325008)
10. D.R. Kapusta, and J.C. Obih Central kappa opioids blunt the renal excretory responses to volume expansion by a renal nerve-dependent mechanism Journal of Pharmacology and Experimental Therapeutics 273 1995 199 205
11. G. Larrinaga, A. Varona, I. Perez, B. Sanz, A. Ugalde, M.L. Candenas, F.M. Pinto, J. Gil, and J.I. Lopez Expression of cannabinoid receptors in human kidney Histology and Histopathology 25 2010 1133 1138
12. J. Li, and D.H. Wang Differential mechanisms mediating depressor and diuretic effects of anandamide Journal of Hypertension 24 2006 2271 2276 (Pubitemid 44611037)
13. 9-tetrahydrocannabinol Journal of Pharmacology and Experimental Therapeutics 319 2006 1211 1218
14. R. Mechoulam Marihuana chemistry Science 168 1970 1159 1166
15. C.A. Paronis, G.A. Thakur, S. Bajaj, S.P. Nikas, V.K. Vemuri, A. Makriyannis, and J. Bergman Diuretic effects of cannabinoids Journal of Pharmacology and Experimental Therapeutics 344 2013 8 14
16. C.A. Paronis, and J.H. Woods Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats European Journal of Pharmacology 337 1997 27 34 (Pubitemid 27468857)
17. R.G. Pertwee Pharmacology of cannabinoid CB1 and CB2 receptors Pharmacology & Therapeutics 74 1997 129 180 (Pubitemid 27337346)
18. R.G. Pertwee, and S.R. Fernando Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder British Journal of Pharmacology 118 1996 2053 2058 (Pubitemid 26292576)
19. G.T. Pryor, S. Husain, F. Larsen, C.E. McKenzie, J.D. Carr, and M.C. Braude Interactions between delta9-tetrahydrocannabinol and phencyclidine hydrochloride in rats Pharmacology Biochemistry and Behavior 6 1977 123 136 (Pubitemid 8079137)
20. M. Rinaldi-Carmona, F. Barth, M. Héaulme, R. Alonso, D. Shire, C. Congy, P. Soubrié, J.C. Brelière, and G. Le Fur Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist Life Sciences 56 1995 1941 1947
21. 2 cannabinoid receptors of L759633, L759656 and AM630 British Journal of Pharmacology 126 1999 665 672 (Pubitemid 29087845)
22. R.D. Sofia, L.C. Knobloch, J.J. Harakal, and D.J. Erikson Comparative diuretic activity of delta9-tetrahydrocannabinol, cannabidiol, cannabinol and hydrochlorothiazide in the rat Archives Internationales de Pharmacodynamie et de Therapie 225 1977 77 87 (Pubitemid 8054205)
23. J. Tam, K.V. Vemuri, J. Liu, S. Bátkai, B. Mukhopadhyay, G. Godlewski, D. Osei-Hyiaman, S. Ohnuma, S.V. Ambudkar, J. Pickel, A. Makriyannis, and G. Kunos Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity Journal of Clinical Investigation 120 2010 2953 2966
24. J.A. Wagner, Z. Jarai, S. Batkai, and G. Kunos Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors European Journal of Pharmacology 423 2001 203 210 (Pubitemid 32614159)
25. J.S. Walczak, T.J. Price, and F. Cervero Cannabinoid CB1 receptors are expressed in the mouse urinary bladder and their activation modulates afferent bladder activity Neuroscience 159 2009 1154 1163
26. J.M. Witkin, E.T. Tzavara, and G.G. Nomikos A role for cannabinoid CB1 receptors in mood and anxiety disorders Behavioural Pharmacology 16 2005 315 331 (Pubitemid 41404804)